You searched for "conjunctiva"
Pupil responses in diabetes
This study aimed to investigate pupillary involvement in patients with type 2 diabetes mellitus (DM) and to evaluate any relationship between severity of diabetic retinopathy (DR) and pupillary responses. Participants included 133 individuals in four groups: proliferative DR (n=21), non-proliferative...
Do patients with prolactinomas using dopamine agonist drugs have autonomic dysfunction?
This prospective study aimed to determine whether there is autonomic dysfunction in patients with prolactinomas using dopamine agonist (DA) drugs by measuring static and dynamic pupillary responses using an automatic pupillometric device.Included were 25 eyes from 25 patients who were...Charity partners celebrate 10 years in Zambia
Vision Aid Overseas and Specsavers are celebrating 10 years of working together.Orbis named winner of 2023 Amazon Web Services IMAGINE grant for non-profits
Orbis will work with Amazon's cloud computing arm to expand access to artificial intelligence-assisted eye screenings in Asia and Africa.
Late stromal rejection in DALK
This case series reported on late stromal rejections in eyes after uncomplicated deep anterior lamellar keratoplasties (DALKs). Four eyes of three patients experienced episodes of isolated stromal rejection 33 to 46 months after surgically uncomplicated DALKs and a minimum of...Study reveals increase in Charles Bonnet Syndrome symptoms due to COVID-19
A study published today in BMJ Open Ophthalmology has shown the impact of COVID-19 on those already experiencing vivid hallucinations as a result of Charles Bonnet syndrome (CBS).Uveal melanoma
Uveal melanoma is the most common primary intraocular tumour. However, they are still rare, with an incidence of 2-8 per million [1]. The presence of a choroidal naevus is a risk factor for uveal melanoma [1]. Patients with choroidal lesions...In conversation with Charles Leclercq (ARxVision)
Julian Jackson (Founder and Director, VisionBridge) spoke to Charles Leclercq (CEO, ARx) about the ARxVision, a wearable device that captures the world around us through audio and artificial intelligence to empower blind and low-vision individuals. You can read the Eye...Management of a giant pigment epithelium detachment with transition from half- to full-dose aflibercept
This case report describes the management of a giant pigment epithelial detachment (PED) in neovascular age-related macular degeneration (nAMD) using half-dose aflibercept. An 80-year-old woman presented with a huge PED (maximum height 1338µm) and multiple risk factors for retinal pigment...The approach to angle-closure glaucoma
Further to my last article in Eye News (print issue) describing the diagnostic approaches to various clinical scenarios in glaucoma, the approach to angle-closure glaucoma (ACG), a situation terrifying for patient and registrar alike, will be discussed. Please refer to...Orbis achieves WHO trachoma elimination threshold in Sheka Zone, Southwest Ethiopia
Ahead of World Neglected Tropical Diseases (NTD) Day on 30 January, international eye care charity Orbis has announced that it has achieved the World Health Organisation (WHO) threshold for eliminating trachoma as a public health concern in Sheka Zone, Southwest...
